FR2444045A1 - Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries - Google Patents

Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries

Info

Publication number
FR2444045A1
FR2444045A1 FR7929992A FR7929992A FR2444045A1 FR 2444045 A1 FR2444045 A1 FR 2444045A1 FR 7929992 A FR7929992 A FR 7929992A FR 7929992 A FR7929992 A FR 7929992A FR 2444045 A1 FR2444045 A1 FR 2444045A1
Authority
FR
France
Prior art keywords
silver
application
production
composition containing
acid salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7929992A
Other languages
English (en)
Other versions
FR2444045B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2444045A1 publication Critical patent/FR2444045A1/fr
Application granted granted Critical
Publication of FR2444045B1 publication Critical patent/FR2444045B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3834Aromatic acids (P-C aromatic linkage)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention a trait au domaine de la chimie pharmaceutique. Elle concerne un sel d'argent d'acide phosphanilique, qui est de préférence le phosphanilate monométallique d'argent ou le phosphanilate dimétallique d'argent, ainsi que son procédé de préparation. Application à l'inhibition du développement de bactéries, notamment Pseudomonas aeruginosa.
FR7929992A 1978-12-11 1979-12-06 Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries Granted FR2444045A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/968,315 US4177199A (en) 1978-12-11 1978-12-11 Silver salts of phosphanilic acid

Publications (2)

Publication Number Publication Date
FR2444045A1 true FR2444045A1 (fr) 1980-07-11
FR2444045B1 FR2444045B1 (fr) 1984-09-14

Family

ID=25514056

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7929992A Granted FR2444045A1 (fr) 1978-12-11 1979-12-06 Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries

Country Status (19)

Country Link
US (1) US4177199A (fr)
JP (1) JPS5585596A (fr)
KR (1) KR830001662B1 (fr)
AU (1) AU524960B2 (fr)
CA (1) CA1192573A (fr)
CH (1) CH645649A5 (fr)
DE (1) DE2949733A1 (fr)
DK (1) DK522979A (fr)
FI (1) FI67856C (fr)
FR (1) FR2444045A1 (fr)
GB (1) GB2036748B (fr)
GR (1) GR74050B (fr)
IE (1) IE49230B1 (fr)
IT (1) IT1164775B (fr)
LU (1) LU81968A1 (fr)
NL (1) NL7908886A (fr)
SE (1) SE444686B (fr)
YU (1) YU43461B (fr)
ZA (1) ZA796640B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1004467A3 (nl) * 1990-06-18 1992-11-24 Sollie Philippe Stikstof- en zilverhoudend derivaat.
US6555333B1 (en) * 2002-05-14 2003-04-29 Pml Microbiologicals, Inc. Broad spectrum fastidious organism culture medium
US20100012892A1 (en) * 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth Whitening Compositions and Methods
WO2010009131A2 (fr) * 2008-07-15 2010-01-21 Basf Catalysts Llc Compositions de polissage des dents et procédés de polissage des dents sans abrasion mécanique
US8311625B2 (en) 2009-02-04 2012-11-13 Basf Corporation Chlorine dioxide treatment for biological tissue

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085688A1 (fr) * 1970-03-10 1971-12-31 Smith Kline French Lab
GB1346544A (en) * 1971-06-01 1974-02-13 Univ Washington Silver allantoinate-containing compositions
US3856805A (en) * 1971-06-16 1974-12-24 Univ Washington Silver zinc allantoin complex

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328358A (en) * 1941-01-23 1943-08-31 Du Pont Organic compound and process for preparing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085688A1 (fr) * 1970-03-10 1971-12-31 Smith Kline French Lab
GB1346544A (en) * 1971-06-01 1974-02-13 Univ Washington Silver allantoinate-containing compositions
US3856805A (en) * 1971-06-16 1974-12-24 Univ Washington Silver zinc allantoin complex

Also Published As

Publication number Publication date
CH645649A5 (fr) 1984-10-15
SE7910160L (sv) 1980-06-12
FI793851A (fi) 1980-06-12
AU524960B2 (en) 1982-10-14
FI67856C (fi) 1985-06-10
AU5365779A (en) 1980-06-19
IT7951033A0 (it) 1979-12-10
LU81968A1 (fr) 1980-07-01
YU245779A (en) 1983-02-28
DK522979A (da) 1980-06-12
FI67856B (fi) 1985-02-28
US4177199A (en) 1979-12-04
IE49230B1 (en) 1985-09-04
ZA796640B (en) 1981-03-25
JPS5585596A (en) 1980-06-27
KR830000906A (ko) 1983-04-28
IT1164775B (it) 1987-04-15
YU43461B (en) 1989-08-31
CA1192573A (fr) 1985-08-27
JPS6254313B2 (fr) 1987-11-13
SE444686B (sv) 1986-04-28
GB2036748B (en) 1983-07-20
GR74050B (fr) 1984-06-06
DE2949733A1 (de) 1980-06-19
IE792381L (en) 1980-06-11
GB2036748A (en) 1980-07-02
NL7908886A (nl) 1980-06-13
KR830001662B1 (ko) 1983-08-23
FR2444045B1 (fr) 1984-09-14

Similar Documents

Publication Publication Date Title
FR2458555B1 (fr) Procede de traitement au phosphite de sels d'acides du phosphore, compositions ainsi produites, concentres et lubrifiants les contenant
FR2446828A1 (fr) N-benzylimidazoles inhibiteurs selectifs de thromboxanne-synthetase, leur procede de production et compositions pharmaceutiques les contenant
FR2450832A1 (fr) Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2410043A1 (fr) Nouveau vaccin contre la mammite de la vache et son procede de production
FR2444031A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2430939A1 (fr) Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant
FR2436602A1 (fr) Composition pharmaceutique renfermant des composes retinoyliques et procede de production de ces composes
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
FR2407926A1 (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
FR2489332B1 (fr) Sels de monoesters d'acide phosphonique, procede pour leur preparation, et compositions fongicides qui les contiennent comme ingredient actif
FR2441627A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
BE1002415A4 (fr) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, ses sels d'addition acides et procede pour les preparer.
FR2447379A1 (fr) Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant
FR2424908A1 (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
FR2444045A1 (fr) Sels d'argent d'acide phosphanilique, leur procede de production, composition antibacterienne les contenant et leur application a l'inhibition de la croissance des bacteries
FR2444674A1 (fr) Derives de n-alcynyl-n'-(omega-((thiazolyle eventuellement substitue)-methylthio)-alkyle) de n''-cyanoguanidine et d'ethylene 1,1-diamino-2-substitue, leur procede de production et medicament les contenant
FR2414509A1 (fr) Procede de cristallisation de cefuroxime sodique
FR2457294A1 (fr) Derives de l'acide penicillanique utiles comme medicaments, compositions therapeutiques les contenant et procedes de leur preparation
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
FR2418789A1 (fr) Nouveaux sels de guanidine, procede permettant leur production et preparations microbicides les contenant
FR2469873A1 (fr) Procedes pour traiter la maladie de l'orme subereux, antibiotique et antimycotique pour leur mise en oeuvre et procede pour leur preparation
FR2506766A1 (fr) Sel de l-lysine ou de dl-lysine de l'acide 5-(p-chlorobenzoyl)-1,4-dimethylpyrrole-2-acetique, son procede de preparation et composition analgesique le contenant
BE1002775A3 (fr) ''(2r,cis)-1,2-epoxypropyl - phosphonate de mono- (2-amonium -2- hydroxymethyl -1,3- propanediol) ayant des caracteristiques ameliorees de stabilite, son procede de preparation et compositions pharmaceutiques le contenant.

Legal Events

Date Code Title Description
ST Notification of lapse